Connect with us

Health

Immunity developed by SARS-CoV-2 infection can protect against E484K variants, suggests study – News-Medical.Net

A team of scientists from Japan has recently investigated the neutralizing potency of convalescent sera against currently circulating SARS-CoV-2 variants with multiple…

Published

on

Article feature image

A team of scientists from Japan has recently investigated the neutralizing potency of convalescent sera against currently circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with multiple spike mutations.
The study’s findings reveal that the variants containing Y543F or N501Y spike mutations are capable of evading neutralization by SARS-CoV-2-induced antibodies. However, no such immune evading potency has been observed for the variants with only the E484K spike mutation.

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Third wave of Covid ‘definitely under way’ in UK, says expert – The Guardian
Best news stories 2021-06-19 – Medical Xpress